. . . "1" . "P(2B06165), V, Z(AV0Z10480505)" . . . "RIV/00216208:11120/12:43904240!RIV13-MSM-11120___" . "US - Spojen\u00E9 st\u00E1ty americk\u00E9" . "Preparation and preclinical evaluation of 177Lu-nimotuzumab targeting epidermal growth factor receptor overexpressing tumors" . "11"^^ . . . . "11120" . "Preparation and preclinical evaluation of 177Lu-nimotuzumab targeting epidermal growth factor receptor overexpressing tumors"@en . . . "0969-8051" . "Monoclonal antibody; 177Lu; Nimotuzumab; Radioimmunotherapy"@en . "RIV/00216208:11120/12:43904240" . "Melichar, Franti\u0161ek" . . . . . "000298936200002" . . . "[3AC20102CFD0]" . "Preparation and preclinical evaluation of 177Lu-nimotuzumab targeting epidermal growth factor receptor overexpressing tumors" . "39" . "1"^^ . . "Nimotuzumab (h-R3) is a humanized monoclonal antibody (mAb) which recognizes the external domain of the epidermal growth factor receptor (EGFR) with high specificity. It was demonstrated that h-R3 has a unique clinical profile for immunotherapy of adult gliomas and pediatric pontine gliomas. The aim of this work was to evaluate the conjugate (177)Lu-h-R3 as a potential radioimmunoconjugate for radioimmunotherapy (RIT) of tumors overexpressing EGFR." . . "10.1016/j.nucmedbio.2011.07.001" . . "161324" . "Preparation and preclinical evaluation of 177Lu-nimotuzumab targeting epidermal growth factor receptor overexpressing tumors"@en . "Nimotuzumab (h-R3) is a humanized monoclonal antibody (mAb) which recognizes the external domain of the epidermal growth factor receptor (EGFR) with high specificity. It was demonstrated that h-R3 has a unique clinical profile for immunotherapy of adult gliomas and pediatric pontine gliomas. The aim of this work was to evaluate the conjugate (177)Lu-h-R3 as a potential radioimmunoconjugate for radioimmunotherapy (RIT) of tumors overexpressing EGFR."@en . "Nuclear Medicine and Biology" . . "6"^^ .